Skip to content

Apotheek Cnudde: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

Apotheek Cnudde

BE 0440.894.989
NACE 47.730, Retail sale of pharmaceutical products
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€113,981
2024 · €140,427-€26,446
Equity
€1.3m
2024 · €1.2m+€68,981
Cash
€267,842
2024 · €270,366-€2,524
Balance sheet total
€1.5m
2024 · €1.4m+€81,265

Largest movements

2024 to 2025
Assets
  • Receivables within one year +€120,213

    up €120,213 (+68.0%), from €176,754 to €296,967

    of which Other amounts receivable: +€74,503

  • Tangible fixed assets -€32,634

    down €32,634 (-4.1%), from €801,152 to €768,518

    of which Land and buildings: -€29,049

Equity and liabilities
  • Reserves +€68,981

    up €68,981 (+5.6%), from €1.2m to €1.3m

    of which Distributable reserves: +€68,981

  • Trade debts +€24,306

    up €24,306 (+27.9%), from €87,024 to €111,330

Income statement
  • Gross operating margin -€40,919

    down €40,919 (-12.6%), from €324,026 to €283,108

  • Taxes -€7,850

    down €7,850 (-12.6%), from €62,508 to €54,657

  • Staff costs -€4,888

    down €4,888 (-5.9%), from €82,646 to €77,759

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €140,427
Gross operating margin -€40,919
Staff costs +€4,888
Depreciation +€691
Other operating charges -€213
Financial income +€1,182
Financial charges +€74
Taxes +€7,850
Result 2025 €113,981
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€42,476
Investment €0
Financing -€45,000
Cash 2024 €270,366
Net result for the year +€113,981
Depreciation +€32,634
Stocks and contracts +€1,671
Receivables within one year -€120,213
Deferred charges and accrued income +€2,119
Trade debts +€24,306
Tax, wage and social debts -€11,401
Other debts -€622
Contributions, distributions and other -€45,000
Cash 2025 €267,842
brings cash intakes cash out
Every line side by side 45 lines
Line Code 2024 2025 Change %
Total assets 20/58 €1,423,773 €1,505,038 +€81,265 +5.7%
Fixed assets 21/28 €802,362 €769,728 -€32,634 -4.1%
Intangible fixed assets 21 €0 - =
Tangible fixed assets 22/27 €801,152 €768,518 -€32,634 -4.1%
Land and buildings 22 €783,656 €754,607 -€29,049 -3.7%
Plant, machinery and equipment 23 €17,496 €13,911 -€3,585 -20.5%
Financial fixed assets 28 €1,210 €1,210 = 0.0%
Current assets 29/58 €621,411 €735,310 +€113,899 +18.3%
Stocks and contracts in progress 3 €168,490 €166,819 -€1,671 -1.0%
Stocks 30/36 €168,490 €166,819 -€1,671 -1.0%
Amounts receivable within one year 40/41 €176,754 €296,967 +€120,213 +68.0%
Trade receivables 40 €144,567 €190,277 +€45,710 +31.6%
Other amounts receivable 41 €32,187 €106,690 +€74,503 +231%
Cash at bank and in hand 54/58 €270,366 €267,842 -€2,524 -0.9%
Deferred charges and accrued income 490/1 €5,800 €3,682 -€2,119 -36.5%
Total equity and liabilities 10/49 €1,423,773 €1,505,038 +€81,265 +5.7%
Equity 10/15 €1,244,927 €1,313,909 +€68,981 +5.5%
Contributions 10/11 €18,592 €18,592 = 0.0%
Reserves 13 €1,226,335 €1,295,317 +€68,981 +5.6%
Non-distributable reserves 130/1 €0 - =
Reserves not available under the articles 1311 €0 - =
Distributable reserves 133 €1,226,335 €1,295,317 +€68,981 +5.6%
Profit (loss) carried forward 14 €0 €0 =
Amounts payable 17/49 €178,845 €191,129 +€12,284 +6.9%
Amounts payable within one year 42/48 €178,845 €191,129 +€12,284 +6.9%
Trade debts 44 €87,024 €111,330 +€24,306 +27.9%
Suppliers 440/4 €87,024 €111,330 +€24,306 +27.9%
Taxes, remuneration and social security 45 €45,177 €33,776 -€11,401 -25.2%
Taxes 450/3 €35,986 €22,933 -€13,053 -36.3%
Remuneration and social security 454/9 €9,191 €10,843 +€1,652 +18.0%
Other amounts payable 47/48 €46,645 €46,023 -€622 -1.3%
Non-recurring operating income 76A €0 - =
Remuneration, social security and pensions 62 €82,646 €77,759 -€4,888 -5.9%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €33,325 €32,634 -€691 -2.1%
Other operating charges 640/8 €5,186 €5,398 +€213 +4.1%
Gross operating margin 9900 €324,026 €283,108 -€40,919 -12.6%
Operating profit (loss) 9901 €202,870 €167,317 -€35,552 -17.5%
Financial income 75/76B €841 €2,023 +€1,182 +141%
Recurring financial income 75 €841 €2,023 +€1,182 +141%
Financial charges 65/66B €776 €702 -€74 -9.6%
Recurring financial charges 65 €776 €702 -€74 -9.6%
Profit (loss) for the period before taxes 9903 €202,935 €168,639 -€34,296 -16.9%
Income taxes 67/77 €62,508 €54,657 -€7,850 -12.6%
Profit (loss) for the period 9904 €140,427 €113,981 -€26,446 -18.8%
Profit (loss) for the period to be appropriated 9905 €140,427 €113,981 -€26,446 -18.8%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 31 October 2026 via checked.be.